MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed

Key highlights
  • Q1 order intake €4.78bn and backlog €15.73bn; Hail & Ghasha ($8.7bn) ~70% complete overall, construction ~50% and expected finished H1 2028.
  • Nextchem Q1 revenues €140.6m (+46%) and EBITDA €32.3m (23%); awarded licensing/PDP and proprietary-equipment contracts for nitrates, urea, SAF (NX PTU™, NX SAF™ BIO) and a trimellitic anhydride plant (NX CONSER™ C5+).
  • Q1: revenues €1.84bn, EBITDA €131.2m, net income €76.7m, adjusted net cash €396.1m; dividend €0.585/sh (€187.6m), €185m sustainability-linked Schuldschein placed, 2026 guidance: group revenues €7.5–7.7bn, EBITDA €545–575m, capex €250–300m.

Q1 2026 results

Revenues €1.84bn (+7.6% vs Q1 2025), EBITDA €131.2m (+15.7%, margin 7.1%), net income €76.7m (+19.9%, margin 4.2%); amortisation and provisions €17.9m; adjusted net cash €396.1m; capex €22.8m and share buy‑back outflows €81.1m; dividend €0.585/share (€187.6m) approved.

Business units

Nextchem (Sustainable Technology Solutions): revenues €140.6m (+46.2%), EBITDA €32.3m (23.0%); awarded licensing/PDP and proprietary equipment contracts for nitrates, urea, specialty chemicals, SAF (NX PTU™, NX SAF™ BIO) and trimellitic anhydride (NX CONSER™ C5+); Ballestra acquisition expected in Q2 2026. Integrated E&C Solutions (Tecnimont & KT): revenues €1.696bn (+5.3%), EBITDA €98.9m, margin 5.8%.

Order intake and backlog

Q1 order intake €4.78bn (IE&CS €4.719bn; STS €60.6m), lifting backlog to €15.73bn, up ≈€3.0bn vs year‑end 2025.

Major projects and financing

Hail & Ghasha ($8.7bn) approximately 70% complete overall and ~50% in construction, with project completion expected in H1 2028; procurement buffers and alternative logistics identified for Middle East sites. MAIRE placed a €185m sustainability‑linked Schuldschein (3- and 5‑year tranches) tied to decarbonization targets, proceeds earmarked for early repayment of facilities.

Guidance

2026 guidance confirmed: Group revenues €7.5–7.7bn, EBITDA €545–575m, capex €250–300m; STS revenues €670–700m; IE&CS revenues €6.8–7.0bn.

Source: Maire

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

30 July 2026
MAIRE: H1 2026 results — €3.7bn revenues, strong order intake and M&A in Nextchem

Revenues +6.9% to €3.68bn; EBITDA +14.7% to €266.2m; H1 order intake €7.2bn, backlog €16.3bn; Nextchem buys Ballestra and 70% of ETEK.

28 April 2026
MAIRE’s Nextchem wins TMA licensing, process design and technical services contract in China with NX CONSER C5+

Continuous TMA production tech delivers power, steam and water savings. TMA feeds PVC plasticizers, coatings and polyester resins. Project in two phases with optional proprietary equipment supply.

28 April 2026
MAIRE's Nextchem awarded NX CONSER C5+ license and process design for TMA plant in China

Licensed process design and technical services for a continuous Trimellitic Anhydride (TMA) plant in China, cuts power, steam and water use; two-phase rollout, optional proprietary equipment.

25 June 2026
Nextchem (MAIRE) completes acquisition of Ballestra Group including Mazzoni and BUSS ChemTech

Adds full NPK fertilizer technologies, fluorine and oleochemistry capabilities; integrates ~460 staff, pilot plants and a €270m backlog; transaction paid at €148.2m.